Skip to content

Other Income - Net at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$4.61M+12.9%
CHE
ChemedCHE
$4.77M+283%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$22.24M-18.7%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$404.17M+10,664%
MYR Group logo
MYR GroupMYRG
-$948K-216%
NNN REIT logo
NNN REITNNN
-$52.7M-11.2%

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$5.03B+533%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s other income - net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s other income - net?
Oruka Therapeutics, Inc. (ORKA) reported other income - net of $4.61M in Q1 2026.
How has Oruka Therapeutics, Inc.'s other income - net changed year-over-year?
Oruka Therapeutics, Inc.'s other income - net increased by 12.9% year-over-year, from $4.09M to $4.61M.
What does other income - net mean?
Captures miscellaneous gains or losses that fall outside the scope of the company's primary business operations. This includes items such as currency fluctuations, asset disposals, or other incidental financial activities.